Indication

Prevention of transient ischemic attack

Prevention of transient ischemic attack refers to therapeutic interventions designed to avert brief episodes of temporary focal neurological dysfunction in individuals at high risk for cerebrovascular events. Read more about Prevention of transient ischemic attack

249 drugs 129 manufacturers

Advertisement

Drugs that treat it

Common Prevention of transient ischemic attack therapies.

Showing 235–243 of 249 drugs

PRAVASTATIN SODIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
REMEDYREPACK, I

SIMVASTATIN

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+13
REMEDYREPACK, I

ASPIRIN

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·ACUTE MYOCARDIAL INFARCTION·+16
MCKESSON MEDICA

SIMVASTATIN

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+13
GSMS, INC.

ASPIRIN

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·ACUTE MYOCARDIAL INFARCTION·+16
HI-TECH NUTRACE

ROSUVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
CRANBURY PHARMA

ROSUVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
AIPING PHARMACE

PRAVASTATIN SODIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
SAFECOR HEALTH

ROSUVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
UMEDICA LABORAT
Filter & compare in the drug finder →Opens the drug finder with Prevention of transient ischemic attack preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Prevention of transient ischemic attack.

Prevention of transient ischemic attack refers to therapeutic interventions designed to avert brief episodes of temporary focal neurological dysfunction in individuals at high risk for cerebrovascular events.

These episodes arise from acute, localized hypoperfusion in the central nervous system—predominantly affecting the brain, spinal cord, or retina—caused by transient microemboli, large-artery atherosclerosis, or cardiac thromboembolism.

Clinically defined by reversible neurological deficits, such as unilateral motor weakness, sensory changes, or language impairment that resolve without evidence of acute infarction on neuroimaging, prevention targets the vascular system to halt progressive cerebral ischemia and diminish the substantial risk of subsequent recurrent ischemia or completed ischemic stroke.

Personalize your experience

Follow Prevention of transient ischemic attack and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it